Sign in

VJNeurology

@vjneurology.bsky.social
118 followers 6 following 315 posts

The Video Journal of Neurology is dedicated to providing up-to-date information & international expertise 🧠 🎥 🗞️ #Headache #Epilepsy #MS #ALS #Stroke #MultipleSclerosis #Migraine #SleepDisorders

PostsRepliesMedia
VJNeurology @vjneurology.bsky.social · 06/08/2026
🧠 Neflamapimod has received ILAP designation in the UK for dementia with Lewy bodies, an important milestone that could help accelerate patient access to innovative treatments. 🎥 Hear Jacqui Cannon discuss what this means for patients. 👉 Watch now: ow.ly/2KXX50ZwT6O @lewybodysociety.bsky.social
000
VJNeurology @vjneurology.bsky.social · 01/07/2026
We’ve just wrapped up an incredible few days at #EAN2026! 🎥🎙️ Watch the first of our coverage here: www.vjneurology.com/event/ean-20... A huge thank you to the organizers and everyone who took the time to speak with us. More exclusive content is on the way - stay tuned! @ean.org
000
Reposted by VJNeurology
European Academy of Neurology @ean.org · 30/06/2026
Welcome to the final day of #ean2026! Check out today's must-see sessions at the EAN Congress 2026 and explore the programme to make the most of your congress experience. 🔗 www.eanvirtualcongress.org
011
VJNeurology @vjneurology.bsky.social · 29/06/2026
Always a pleasure speaking with Celia Oreja-Guevara. She discussed the recent approval of tolebrutinib in the EU, how AI will change MS care, managing patients with MS during menopause, & more! Stay tuned to VJNeurology.com for the full interview 📹 #EAN2026 @ean.org
000
VJNeurology @vjneurology.bsky.social · 29/06/2026
Another great interview at #EAN2026 with Michael Leo Strupp on the Phase III trial evaluating levacetylleucine in ataxia-telangiectasia. Interested in the findings? Full interview coming soon to vjneurology.com 📹 #Neurology #NeuroTwitter @ean.org
000
VJNeurology @vjneurology.bsky.social · 29/06/2026
Day 3 of #EAN2026 is well underway! We just did a wonderful interview with Katarina Rukavina on hormonal changes during menopause in PD, how to differentiate between symptoms of menopause and PD, and managing menopausal symptoms. Coming soon to vjneurology.xn--com-rm23b @ean.org
000
VJNeurology @vjneurology.bsky.social · 28/06/2026
#EAN2026 | New data from an analysis of the Myasthenia Gravis Inebilizumab Trial (MINT) were presented today presented by Richard Nowak. Watch now 👇 www.vjneurology.com/video/x5az6-... #Neurology @ean.org
vjneurology.com
Adverse events of special interest during the RCP: Myasthenia Gravis Inebilizumab Trial
Richard Nowak, MD, MS, Yale School of Medicine, New Haven, CT, discusses adverse events of special interest during the randomized...
000
VJNeurology @vjneurology.bsky.social · 28/06/2026
It is always a pleasure to speak with Tiago Outeiro. Today, he discussed the current concept of synucleinopathies in the era of biomarkers, PD beyond dopaminergic neurons, and more. Coming soon to www.vjneurology.com/%F0%9F%91%80 #EAN2026 #Neurology #Parkinsons
000
VJNeurology @vjneurology.bsky.social · 28/06/2026
It was wonderful to catch up with Rigmor Hojland Jensen at #EAN2026! She shared key takeaways from a session on spontaneous intracranial hypotension and updates on the management of medication-overuse headache. #Headache #Neurology #NeuroTwitter
000
VJNeurology @vjneurology.bsky.social · 28/06/2026
🧠 #EAN2026 | Earlier today, Joost Smolders presented on broad rim lesions in multiple sclerosis. 🎥 Watch our exclusive interview with him👇 www.vjneurology.com/video/r2d__r...
vjneurology.com
What is currently known about broad rim lesions in multiple sclerosis?
Joost Smolders, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands, gives an overview of what is currently known about broad...
000
VJNeurology @vjneurology.bsky.social · 28/06/2026
🧠 Tomorrow at #EAN2026, Alicja Kalinowska will take part in a thought-provoking debate on a key question in multiple sclerosis research: Does prodromal MS exist? 🎥 We caught up with Prof. Kalinowska ahead of the session to hear her perspective. Stay tuned on VJNeurology.com 👀 @ean.org
000
VJNeurology @vjneurology.bsky.social · 28/06/2026
🎥 Day 2 of #EAN2026 kicks off with an insightful interview with Dr Nowak, covering the latest updates from the Myasthenia Gravis Inebilizumab Trial, nipocalimab from the Vivacity-MG3 study, and more! Stay tuned to VJNeurology.com 👀 #Neurology #MyastheniaGravis @ean.org
000
VJNeurology @vjneurology.bsky.social · 27/06/2026
🧠 We caught up with Zenglin Cai at #EAN2026 to discuss a Phase I trial investigating autologous SVF therapy for ALS. 🎥 Stay tuned to hear the results - coming soon to VJNeurology.com 👀 #ALS #Neurology #MND
000
VJNeurology @vjneurology.bsky.social · 27/06/2026
🧠 #EAN2026 | Francesca Morgante just gave a presentation titled "Optimizing L-Dopa Therapy: Current Limits of Efficacy and Clinical Application." 🎥 In this exclusive interview, she breaks down the key takeaways from her presentation. Watch now 👇 ow.ly/oJGV50ZhTOm @ean.org #Neurology
ow.ly
Current limits of L-DOPA therapy in PD and approaches to optimization
Francesca Morgante, MD, PhD, St George’s University of London, London, United Kingdom, discusses the current limits of levodopa (L-DOPA) therapy...
000
Reposted by VJNeurology
European Academy of Neurology @ean.org · 27/06/2026
Make sure to catch this afternoon's must-see sessions at the EAN Congress 2026! Download the congress app or use the web version of the congress platfrom to plan your calendar over the next days and make the most of your tightly packed schedule! ➡️ www.eanvirtualcongress.org #ean2026 #neurology
021
VJNeurology @vjneurology.bsky.social · 27/06/2026
A huge thank you to @MRomozzi for speaking with us at #EAN2026 about her exciting research on PACAP-38 in the tear fluid of patients with migraine, as well as the TRIPLE study, which is investigating triple combination therapy for chronic migraine. #Neurology #Migraine #ChronicMigraine @ean.org
000
VJNeurology @vjneurology.bsky.social · 27/06/2026
🧠 Tomorrow at #EAN2026, Joost Smolders will present "Broad rim lesions as a new biomarker for rapid disease progression in multiple sclerosis." 🎥 Stay tuned for this interview where he discusses the key takeaways! Coming soon to VJNeurology.com 👀 #Neurology #MultipleSclerosis #MS @ean.org
000
VJNeurology @vjneurology.bsky.social · 27/06/2026
🧠 Optimizing L-Dopa therapy, device-aided therapies, and which breakthrough in Parkinson's disease could transform patient care over the next three years? 🎥 We caught up with Francesca Morgante at #EAN2026 to discuss these key topics - coming soon! #ParkinsonsDisease #PD #Neurology @ean.org
000
VJNeurology @vjneurology.bsky.social · 27/06/2026
At #EAN2026, Alessandro Visentini is presenting a poster on "Eptinezumab for Difficult-to-Treat Migraine: Who Responds and Who Needs More?" 🧠 🎥 We caught up with him to discuss the key findings and clinical implications. Stay tuned on VJNeurology.com 👀 #Neurology #Migraine #Headache @ean.org
000
Reposted by VJNeurology
European Academy of Neurology @ean.org · 27/06/2026
We are delighted to welcome neurologists, researchers, and healthcare professionals from around the world as #EAN2026 officially begins today! Join us over the coming four days for inspiring sessions, cutting-edge science, and valuable connections shaping the future of neurology. Welcome!
051
VJNeurology @vjneurology.bsky.social · 27/06/2026
📍 We’re LIVE on-site at #EAN2026! 🇨🇭🧠 🎥 Our expert interviews are now underway, bringing you the latest insights from leaders in neurology. Follow @vjneurology.bsky.social for live updates and keep an eye on vjneurology.com for exclusive coverage coming soon! 👀✨ #Neurology @ean.org
000
VJNeurology @vjneurology.bsky.social · 11/11/2025
In a recent interview, Heather Angus-Leppan discussed the under-recognition of psychiatric comorbidities in late-onset epilepsy, describing them as the “hidden iceberg” due to a lack of research. Watch here: 👉 buff.ly/DLvzbrR 👈 #Neuroscience #MedSky #IEC2025 #Neurology
000
VJNeurology @vjneurology.bsky.social · 10/11/2025
It was great to speak with Rolf Wachter at #WSC2025 to hear about the association of premature atrial complexes with atrial fibrillation & #stroke risk. 🧠 Want to find out more? 🎥 Watch the interview here: 👉 buff.ly/X6Tl7pB #Neuroscience #Neurology #MedSky
000
VJNeurology @vjneurology.bsky.social · 07/11/2025
We recently spoke with Siegward Elsas as part of our coverage of #IEC2025 to hear about unanswered questions and ongoing research into Huperzine A for the treatment of #epilepsy. 🧠 Watch here: 🎥 buff.ly/T7hBDUg #MedSky #Neuroscience #Neurology
000
VJNeurology @vjneurology.bsky.social · 06/11/2025
In an interview from #WSC2025, the lovely Bindu Menon introduces the EduWAND initiative, which aims to educate women in India about neurological disorders. Click here to watch: 👉 buff.ly/mBvrfvF #Stroke #Neuroscience #Neurology #MedSky
000
VJNeurology @vjneurology.bsky.social · 05/11/2025
🎥 Aurelie Hanin discusses the use of immunotherapy in patients with new-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): 👉 buff.ly/PMBKL8U 👈 #epilepsy #Neurology #Neuroscience #MedSky
110
VJNeurology @vjneurology.bsky.social · 04/11/2025
It was fantastic to catch up with Aristeidis Katsanos at #WSC2025 to hear about inflammation as a new target for improving outcomes in intracerebral hemorrhage. 🧠 Watch the interview here: 👉 buff.ly/Iachojf #Stroke #Neuroscience #Neurology #MedSky
000
VJNeurology @vjneurology.bsky.social · 03/11/2025
Want to hear about the OCEANIC-STROKE trial investigating asundexian as secondary #stroke prevention in participants who have had an acute ischemic stroke or high-risk transient ischemic attack? Watch our interview with Mike Sharma from #WSC2025: 🎥 buff.ly/pkZ0w6z #Neurology #MedSky
000
VJNeurology @vjneurology.bsky.social · 31/10/2025
At #WSC2025, the lovely Kathy Trieu of @georgeinstitute.bsky.social discussed a multifaceted strategy to switch the world’s salt supply to potassium-rich salt for cardiovascular disease and #stroke prevention. Watch here: 👉 buff.ly/NhRDgpV #Neuroscience #Neurology #MedSky
011
VJNeurology @vjneurology.bsky.social · 30/10/2025
Last week at #WSC2025, we had the pleasure of catching up with Valeria Caso to hear about the limitations of anticoagulation for #stroke prevention in patients with atrial fibrillation. Watch here: 👉 buff.ly/BYHV27l #Neurology #MedSky
010
VJNeurology @vjneurology.bsky.social · 29/10/2025
🎥 Elissa Yozawitz discusses the treatment of neonatal seizures, outlining first- and second-line options: 👉 buff.ly/5p0xCyy 👈 #Epilepsy #Neuroscience #Neurology #MedSky
010
VJNeurology @vjneurology.bsky.social · 29/10/2025
Earlier this year, we spoke with Dr Terry Quinn, who discussed the link between #stroke & #dementia, and commented on the role of cognitive screening. 🧠 Click here to watch this insightful interview: 🎥 buff.ly/d76MC7c #WorldStrokeDay #StrokeAwareness #NeuroSky #MedSky
000
VJNeurology @vjneurology.bsky.social · 29/10/2025
Does hormonal contraception increase the risk of #stroke in young women? 💊👩 Dr Mine Sezgin provided insight into this in an interview at #ESOC2025.🎥 Watch it here: 👉 buff.ly/QlLen8o #WorldStrokeDay #StrokeAwareness #MedSky #NeuroSky
000
VJNeurology @vjneurology.bsky.social · 28/10/2025
🎥 Rani Sarkis comments on the growing understanding of juvenile myoclonic epilepsy as a heterogeneous condition and highlights approaches to better tailor treatment to individual patients: 👉 buff.ly/aOmTs0O 👈 #IEC2025 #NeuroSky #Neurology #MedSky
000
VJNeurology @vjneurology.bsky.social · 27/10/2025
In an insightful recent interview, Pablo Casillas of @monashuniversity.bsky.social comments on the lack of research on sex differences in #epilepsy, attributing it to biases in #neuroscience research. Learn more: 👉 buff.ly/Pr1Cj4n 👈 #MedSky #NeuroSky
010
VJNeurology @vjneurology.bsky.social · 23/10/2025
Join us for our Post-World #Stroke Congress 2025 Highlights 🧠 💻 Featuring presentations & discussions on selected abstracts from the 17th World Stroke Congress (WSC) 🔦 🗓️ Tuesday 2 December 2025 | 8 – 10am CST / 2 – 4pm GMT / 3 – 5pm CET Agenda coming soon 👀 REGISTER NOW ✍️ 👉 buff.ly/sNV2Uec
000
VJNeurology @vjneurology.bsky.social · 22/10/2025
We recently spoke with Prof. Heather Angus-Leppan, who highlighted the prevalence of psychiatric comorbidities, particularly depression and anxiety, in older adults with #epilepsy. Learn more here: 🎥 buff.ly/24aE57p #NeuroSky #MedSky #IEC2025 #Neurology
000
VJNeurology @vjneurology.bsky.social · 21/10/2025
In a recent interview, Siegward Elsas outlines the mechanism of action of huperzine A as an anti-seizure medication and discusses its clinical activity in #epilepsy. Click here to watch: 👉 buff.ly/LV9Gj19 👈 #IEC2025 #MedSky #NeuroSky #Neurology
000
VJNeurology @vjneurology.bsky.social · 17/10/2025
Disparities in the delivery of #stroke care exist across Europe.🧠 Earlier this year, we interviewed Diana Sousa to gain valuable insight into this. Click here to watch the interview: 👉 buff.ly/iYi6Jew 👈 #Neuroscience #Neurology #EAN2025 #MedSky
000
VJNeurology @vjneurology.bsky.social · 16/10/2025
Want to learn about the associations in the pathophysiology of #depression and #epilepsy? 🧠 Check out our interview with Rani Sarkis from #IEC2025 here: 👉 buff.ly/ifkNq4u 👈 #Neuroscience #Neurology #MedSky
010
VJNeurology @vjneurology.bsky.social · 15/10/2025
#IEC2025 | In a recent interview, Silvia Cases-Cunillera comments on the complex link between tumor biology and seizure generation in #epilepsy. Click here to learn more: 👉 buff.ly/UAIi0go 👈 #Neuroscience #Neurology #MedSky
000
VJNeurology @vjneurology.bsky.social · 14/10/2025
At #EAN2025, Alberto De Lorenzo discussed how large language models, such as ChatGPT, will support clinicians in the diagnosis and management of polyneuropathy. Watch here: 🎥 buff.ly/Apb7BGc #Neuroscience #Neurology #MedSky
000
VJNeurology @vjneurology.bsky.social · 13/10/2025
Are there significant sex differences in cognition among patients with #epilepsy? 🚹 🚺 Watch our recent #IEC2025, in which Pablo Casillas of @monashuniversity.bsky.social outlines the data on this topic: 🎥 buff.ly/sMj4FPr #Neurology #Neuroscience #MedSky
000
VJNeurology @vjneurology.bsky.social · 10/10/2025
🎥 Gerard Maya discusses the monitoring of patients with idiopathic REM sleep behavior disorder for neurodegenerative diseases: 👉 buff.ly/fu39uFQ 👈 #SleepResearch #Neuroscience #Neurology #MedSky
000
VJNeurology @vjneurology.bsky.social · 09/10/2025
In an interview from #IEC2025, Aureline Hanin outlines the potential mechanisms underlying innate immunity dysregulation in NORSE/FIRES. Watch here: 👉 buff.ly/VxVbYtp 👈 #epilepsy #MedSky #Neurology
000
VJNeurology @vjneurology.bsky.social · 08/10/2025
Watch our recent interview with Elissa Yozawitz, in which she provides insight into the International League Against Epilepsy (ILAE) neonatal seizure framework. 🎥 Click here: 👉 buff.ly/Z7NWpYt 👈 #Epilepsy #Neurology #Neuroscience #MedSky
000
VJNeurology @vjneurology.bsky.social · 07/10/2025
#IEC2025 | @ranisarkismd.bsky.social provides insight into the potential link between amyloid buildup and #epilepsy, suggesting that amyloid may be pro-epileptogenic: 🎥 👉 buff.ly/cqsfnom @ilae-epilepsy.bsky.social #Neuroscience #Neurology #MedSky
000
VJNeurology @vjneurology.bsky.social · 06/10/2025
In an interview from #EAN2025, David Oliver comments on the complexities of assisted dying for patients with neurological diseases, highlighting the potential vulnerabilities of patients. Watch here: 👉 buff.ly/Njqwqk9 #Neurology #Neuroscience #MedSky
000
VJNeurology @vjneurology.bsky.social · 03/10/2025
Learn about the potential use of plasma ptau217 as a biomarker in patients with late-onset unexplained #epilepsy by watching our recent interview with @ranisarkismd.bsky.social here: 🎥 👉 buff.ly/uyiD3Df @ilae-epilepsy.bsky.social #Neurology #Neuroscience #MedSky
010
VJNeurology @vjneurology.bsky.social · 02/10/2025
🎥 Marcello Moccia comments on the association between neurofilament and invisible symptoms of #MultipleSclerosis, including cognitive dysfunction, depression, and fatigue: 👉 buff.ly/eW8A7YG 👈 #MS #MultScler #Neuroscience #Neurology #EAN2025 #MedSky
010